From the Journals

Heavy drinking did not worsen clinical outcomes from drug-induced liver injury

Publish date: May 1, 2018

 

FROM CLINICAL GASTROENTEROLOGY AND HEPATOLOGY


Funders included the National Institute of Diabetes and Digestive and Kidney Diseases and the National Cancer Institute. Dr. Dakhoul had no conflicts of interest. On coinvestigator disclosed ties to numerous pharmaceutical companies.

SOURCE: Dakhoul L et al. Clin Gastro Hepatol. 2018 Jan 3. doi: 10.1016/j.cgh.2017.12.036.

Pages

Recommended Reading

VIDEO: Pioglitazone benefited NASH patients with and without T2DM
MDedge Internal Medicine
VIDEO: Biomarker accurately predicted primary nonfunction after liver transplant
MDedge Internal Medicine
Pre-screening could help identify NAFLD biopsy candidates
MDedge Internal Medicine
Red meat intake linked to NAFLD risk
MDedge Internal Medicine
Switching to tenofovir alafenamide may benefit HBV patients
MDedge Internal Medicine
Survival worse with alcohol-related HCC, compared with other types
MDedge Internal Medicine
MicroRNAs flag liver damage in HIV-, HCV-infected persons
MDedge Internal Medicine
MDedge Daily News: Can androgen therapy improve male frailty?
MDedge Internal Medicine
DAAs open up organ donation from HCV patients
MDedge Internal Medicine
Hep B therapy: Indefinite or FINITE for e-negative patients?
MDedge Internal Medicine